Skip to main content
Advanced Technical IVT

in-stent restenosis

Also written as: ISR — In-stent restenosis

Re-narrowing of a coronary artery within or adjacent to a previously implanted stent, typically defined as >50% diameter stenosis.

Full Definition

In-stent restenosis (ISR) is the re-narrowing of a coronary artery segment within or immediately adjacent to a previously placed stent, usually defined as >50% diameter stenosis on angiography. This complication results from neointimal hyperplasia in response to vessel injury and foreign body reaction. Drug-eluting stents significantly reduced ISR rates compared to bare metal stents, from approximately 20-30% to <10%. In cardiovascular research, ISR serves as a key safety endpoint for device trials and a target for novel therapeutic approaches. Editors should verify that ISR definitions, timing of assessment, and measurement methods are clearly specified in stent-related studies.

Usage

Usage note: Hyphenate when used as compound adjective. Specify stenosis threshold (typically 50%) and assessment timepoint.

In Context

  • "Angiographic in-stent restenosis at 9 months occurred in 8.2% of drug-eluting stent patients." — Stent efficacy trial
  • "Treatment of in-stent restenosis with drug-coated balloons showed promising results." — Device innovation study

Also known as

ISR stent restenosis neointimal hyperplasia

Contrasted with

stent patency

Don't confuse with

stent thrombosis target lesion revascularization progression of disease

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON